|
2020 Journal Article Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free dietDaveson, A. James M., Popp, Alina, Taavela, Juha, Goldstein, Kaela E., Isola, Jorma, Truitt, Kenneth E., Mäki, Markku, Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Chen Yi Mei, S., Coates, A., Daveson, A.J., DiMarino, A., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R., Holtmann, G., Idarraga, S. ... Wilson, S. (2020). Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet. GastroHep, 2 (1), 22-30. doi: 10.1002/ygh2.380 |
|
2019 Journal Article Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac diseaseDaveson, A. James M., Tye-Din, Jason A., Goel, Gautam, Goldstein, Kaela E., Hand, Holly L., Neff, Kristin M., Williams, Leslie J., Truitt, Kenneth E., Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Mei, S. Chen Yi, Coates, A., Daveson, A. J. M., DiMarino, A., Ee, H., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R. ... Wilson, S. (2019). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology & Therapeutics, 51 (2), 244-252. doi: 10.1111/apt.15551 |
|
2017 Journal Article Epitope Specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studiesGoel, Gautam, King, Tim, Daveson, A. James, Andrews, Jane M., Krishnarajah, Janakan, Krause, Richard, Brown, Gregor J. E., Fogel, Ronald, Barish, Charles F., Epstein, Roger, Kinney, Timothy P., Miner Jr, Philip B., Girardin, Adam, Tye-Din, Jason A., Girardin, Adam, Taavela, Juha, Popp, Alina, Sidney, John, Maki, Makku, Goldstein, Kaela E., Griffin, Patrick H., Wang, Suyue, Dzuris, John L., Williams, Leslie J., Sette, Alessandro, Xavier, Ramnik J., Sollid, Ludvig M., Jabri, Bana and Anderson, Robert P. (2017). Epitope Specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. The Lancet Gastroenterology and Hepatology, 2 (7), 479-493. doi: 10.1016/S2468-1253(17)30110-3 |
|
2011 Journal Article Effect of hookworm infection on wheat challenge in celiac disease - A randomised double-blinded placebo controlled trialDaveson, A. James, Jones, Dianne M., Gaze, Soraya, McSorley, Henry, Clouston, Andrew, Pascoe, Andrew, Cooke, Sharon, Speare, Richard, Macdonald, Graeme A., Anderson, Robert, McCarthy, James S., Loukas, Alex and Croese, John (2011). Effect of hookworm infection on wheat challenge in celiac disease - A randomised double-blinded placebo controlled trial. PLoS One, 6 (3, Article number e17366) e17366, e17366-1-e17366-9. doi: 10.1371/journal.pone.0017366 |
|
2025 Journal Article Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trialDaveson, A. James M., Stubbs, Richard, Polasek, Thomas M., Isola, Jorma, Anderson, Robert, Tye-Din, Jason A., Schoeman, Mark, Lionnet, Claudette, Mei, Swee Lin Chen Yi, Mihajlović, Jelena, Wirth, Martina, Peelen, Evelyn, Schreieck, Amelie, Kohlhof, Hella, Vitt, Daniel, Muehler, Andreas and Buriánek, Franziska (2025). Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Gastroenterology and Hepatology, 10 (1), 44-54. doi: 10.1016/s2468-1253(24)00248-6 |
|
2024 Journal Article Splenic artery collateral masquerading as a gastric varix post splenic traumaDaveson, A.J.M., O’Rourke, T. and Davis, S. (2024). Splenic artery collateral masquerading as a gastric varix post splenic trauma. Gastrointestinal Endoscopy, 99 (1), 120-121. doi: 10.1016/j.gie.2023.07.004 |
|
2023 Journal Article Undiagnosed coeliac disease identified by active case finding in first degree relatives of people with coeliac disease in Australia: a prospective observational studyMuir, Richard, Sehgal, Anuj, Tye‐Din, Jason A and Daveson, A James M (2023). Undiagnosed coeliac disease identified by active case finding in first degree relatives of people with coeliac disease in Australia: a prospective observational study. Medical Journal of Australia, 219 (8), 371-373. doi: 10.5694/mja2.52105 |
|
2023 Journal Article High incidence of inflammatory bowel disease in Northern Australia: a prospective community population‐based Australian incidence study in the Mackay‐Isaac‐Whitsunday regionFlanagan, Amanda, Allsopp, Susan M., O'Connor, Sam A., Tobin, Jacinta, Pretorius, Casper, Brown, Ian S., Bell, Sally and Daveson, A. James M. (2023). High incidence of inflammatory bowel disease in Northern Australia: a prospective community population‐based Australian incidence study in the Mackay‐Isaac‐Whitsunday region. Internal Medicine Journal, 53 (9), 1602-1609. doi: 10.1111/imj.15941 |
|
2023 Journal Article Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 studyTye-Din, Jason A, Daveson, A James M, Goel, Gautam, Goldstein, Kaela E, Hand, Holly L, Neff, Kristin M, Popp, Alina, Taavela, Juha, Maki, Markku, Isola, Jorma, Williams, Leslie J, Truitt, Kenneth E, Anderson, Robert P, Adams, Atoya, Andrews, Jane M, Behrend, Clint E, Brown, Gregor J E, Chen Yi Mei, Swee Lin, Coates, Allan G, DiMarino, Anthony J, Ee, Hooi, Elliott, David E, Epstein, Roger M, Feyen, Bryan John, Fogel, Ronald P, Friedenberg, Keith Alan, Gearry, Richard B, Gerdis, Michael S, Goldstein, Michael J ... Wilson, Scott A (2023). Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study. The Lancet Gastroenterology and Hepatology, 8 (5), 446-457. doi: 10.1016/s2468-1253(22)00428-9 |
|
2023 Conference Publication High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday regionFlanagan, A., O'Connor, S., Allsop, S., Tobin, J., Pretorius, C., Brown, I., Bell, S. and Daveson, A. J. (2023). High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region. OXFORD: OXFORD UNIV PRESS. |
|
2023 Conference Publication High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday regionFlanagan, A., O'Connor, S., Allsop, S., Tobin, J., Pretorius, C., Brown, I., Bell, S. and Daveson, A. J. (2023). High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region. 18th Congress of ECCO, Copenhagen, Denmark, 1-4 March 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjac190.1010 |
|
2022 Journal Article Tattoo sarcoidosis presenting as abdominal allodyniaFaint, Annabelle and Daveson, A. James M. (2022). Tattoo sarcoidosis presenting as abdominal allodynia. Medical Journal of Australia, 217 (1), 23-23. doi: 10.5694/mja2.51603 |
|
2020 Journal Article Patient factors influencing acute gluten reactions and cytokine release in treated coeliac diseaseTye-Din, Jason A., Daveson, A. James M., Goldstein, Kaela E., Hand, Holly L., Neff, Kristin M., Goel, Gautam, Williams, Leslie J., Truitt, Kenneth E., Anderson, Robert P., RESET CeD Study Group and Holtmann, G. (2020). Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease. BMC medicine, 18 (1) 362, 362. doi: 10.1186/s12916-020-01828-y |
|
2020 Journal Article Editorial: inaccuracies in attribution of symptoms due to gluten—not just in those with self-reported noncoeliac gluten sensitivity. Authors' replyDaveson, A. James M., Tye-Din, Jason A. and Anderson, Robert P. (2020). Editorial: inaccuracies in attribution of symptoms due to gluten—not just in those with self-reported noncoeliac gluten sensitivity. Authors' reply. Alimentary Pharmacology and Therapeutics, 51 (3), 403-404. doi: 10.1111/apt.15629 |
|
2019 Journal Article Serum cytokines elevated during gluten-mediated cytokine release in coeliac diseaseGoel, G., Daveson, A. J. M., Hooi, C. E., Tye-Din, J. A., Wang, S., Szymczak, E., Williams, L. J., Dzuris, J. L., Neff, K. M., Truitt, K. E. and Anderson, R. P. (2019). Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease. Clinical and Experimental Immunology, 199 (1) cei.13369, 68-78. doi: 10.1111/cei.13369 |
|
2019 Journal Article Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac diseaseTye-Din, Jason A., Daveson, A. James M., Ee, Hooi C., Goel, Gautam, MacDougall, James, Acaster, Sarah, Goldstein, Kaela E., Dzuris, John L., Neff, Kristin M., Truitt, Kenneth E. and Anderson, Robert P. (2019). Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. Alimentary Pharmacology and Therapeutics, 50 (8), 901-910. doi: 10.1111/apt.15477 |
|
2019 Journal Article Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac diseaseTruitt, Kenneth E., Daveson, A. James M., Ee, Hooi C., Goel, Gautam, MacDougall, James, Neff, Kristin and Anderson, Robert P. (2019). Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease. Alimentary Pharmacology & Therapeutics, 50 (5), 547-555. doi: 10.1111/apt.15435 |
|
2018 Journal Article High rates of variation in HLA-DQ2/DQ8 testing for coeliac disease: results from an RCPAQAP pilot programHoran, Martin Patrick, Chai, Sze Yee, Munusamy, Nalishia, Tay, Kwang Hong, Wienholt, Louise, Tye-Din, Jason A, Daveson, James, Varney, Michael and Badrick, Tony (2018). High rates of variation in HLA-DQ2/DQ8 testing for coeliac disease: results from an RCPAQAP pilot program. Journal of Clinical Pathology, 71 (10), jclinpath-2018. doi: 10.1136/jclinpath-2018-205209 |
|
2017 Journal Article Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 StudyDaveson, A. James M., Ee, Hooi C., Andrews, Jane M., King, Timothy, Goldstein, Kaela E., Dzuris, John L., MacDougall, James A., Williams, Leslie J., Treohan, Anita, Cooreman, Michael P. and Anderson, Robert P. (2017). Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study. EBioMedicine, 26, 78-90. doi: 10.1016/j.ebiom.2017.11.018 |
|
2017 Journal Article Discrepancies in genetic testing results for coeliac disease: call for standardised testing and reportingDaveson, A. James M. , Varney, Michael, Jackson, Kate E. and Tye-Din, Jason A. (2017). Discrepancies in genetic testing results for coeliac disease: call for standardised testing and reporting. Medical Journal Australia, 207 (4), 179-180. doi: 10.5694/mja17.00314 |
